← Open Payments lookup

MARCUS WITZEL: Open Payments

NPI 1265177661 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,698 in 90 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $765 · 2025 $1,698

Food & beverage: $1,698
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$530
Otsuka America Pharmaceutical, Inc.16$272
ABBVIE INC.14$223
Takeda Pharmaceuticals U.S.A., Inc.7$136
Axsome Therapeutics, Inc.6$135
Alkermes, Inc.4$82
Teva Pharmaceuticals USA, Inc.3$68
Vanda Pharmaceuticals Inc.3$63
Supernus Pharmaceuticals, Inc.3$60
Corium, LLC3$53

Products named: CAPLYTA, REXULTI, VRAYLAR, TRINTELLIX, Auvelity, AUSTEDO XR, FANAPT, Qelbree.

Industry payments across AL — which companies pay providers there.